Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of food-associated allergic and inflammatory diseases.

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

particularly follicular helper T (Tfh) cells and Th17 cells, and has been shown to be extensively involved in regulating both innate and adaptive immunity. IL-21 is particularly significant in the ...

State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing 210003,China ...

CD3, or cluster of differentiation 3, is a protein complex and T cell co-receptor that is involved in activating both cytotoxic T cells and T helper cells. T cells, also known as T lymphocytes, are a ...

If you or someone you love lives with sickle cell, you already know the story. The ER visits. The unpredictable pain. The fatigue that doesn’t go away. The fear of strokes, infections, and organ ...

Clearance mechanisms not based on FcRn, such as the asialoglycoprotein receptor, T-cell mediated cytotoxicity, or classical FcγRs, may limit the response to this approach in patients with ITP.

EchoBack CAR T-cells are smart immune warriors that respond to ultrasound to fight cancer longer and more safely than ever before. They promise a big leap in treating solid tumors. Credit: ...

CAR T-cell therapy offers the possibility of long-term remission, even cure, for patients whose lymphoma resisted other treatments or has returned shortly after initial treatment. When a patient ...

--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS), today announced that the ...